Condition: Melasma · Sponsor: Dr.dr.Irma Bernadette, SpKK (K)
This research is a clinical study with a single-blind randomized clinical trial design (randomized controlled trial) in RSCM-FKUI This study aims to Assess the effectiveness and safety of intradermal concentrated secretome injection therapy, triple combination cream, and intradermal tranexamic acid injection in melasma patients, determine the quality of life profile of melasma patients after triple combination cream therapy in melasma therapy, and determine SOD levels in melasma patients. This research will be attended by 90 research subjects
This description comes directly from the study's public registry record.
Prof. Dr. dr. Irma Bernadette S. Sitohang, SpKK(K) Sitohang · +62818130761 · irma_bernadette@yahoo.com
Prof. Dr. dr. Irma Bernadette S. Sitohang, SpKK(K) Sitohang Sitohang · +62818130761 · irma_bernadette@yahoo.com
Always discuss trial participation with your own doctor first.
| Clinical Research Supporting Unit- Faculty of Medicine, University of Indonesia | Jakarta Pusat, DKI Jakarta, Indonesia | Recruiting |
| Dr. Cipto Mangunkusumo Hospital | Jakarta Pusat, DKI Jakarta, Indonesia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06516419